Skip to main content
. 2021 Jan 20;11:583485. doi: 10.3389/fneur.2020.583485

Table 1.

Demographic data and selected comorbidities of the study subjects.

Variables All Non-CHMs users CHMs users p-value*
n = 26,743(%) n = 26,743(%)
Age (yr) 0.44
≤50 28,771 (53.8) 14,341 (53.6) 14,430 (54.0)
>50 24,715 (46.2) 12,402 (46.4) 12,313 (46.0)
Mean (SD) 48.5 ± 12.4 48.5 ± 12.3 48.5 ± 12.5 0.97
Gender 0.69
Female 34,224 (64.0) 17,090 (63.9) 17,134 (64.1)
Male 19,262 (36.0) 9,653 (36.1) 9,609 (35.9)
Monthly income 0.40
Low 24,988 (46.7) 12,417 (46.4) 12,571 (47.0)
Median 26,037 (48.7) 13,095 (49.0) 12,942 (48.4)
High 2,461 (4.6) 1,231 (4.6) 1,230 (4.6)
Residential area 0.96
Urban 30,911 (57.8) 15,454 (57.8) 15,457 (57.8)
Suburban 8,420 (15.7) 4,221 (15.8) 4,199 (15.7)
Rural 14,155 (26.5) 7,068 (26.4) 7,087 (26.5)
CCI 0.28
Mean (SD) 4.0 (6.7) 3.9 (6.6) 4.0 (6.8)

CHMs, Chinese herbal medicines; SD: standard deviation; CCI, Charlson-Deyo comorbidity index.

*

All p-values were derived from chi-square test, except for CCI that was calculated with independent Student's t-test.